40 studies found for:    " December 16, 2009":" January 15, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" December 16, 2009":" January 15, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (40 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Condition: HIV Infections
Intervention:
2 Completed Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Conditions: HIV Infection;   HIV Infections
Intervention: Genetic: SB-728-T
3 Unknown  Medications for Chronic HIV: Education and Collaboration
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Medication Adherence
Intervention: Behavioral: MedCHEC tablet computer and Adherence Care
4 Completed TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions
Condition: HIV Infections
Intervention: Drug: DRV commercial formulation/ DRV new formulation/ rtv 100mg tab
5 Completed
Has Results
Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: ARV (non-raltegravir)
6 Completed Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study
Condition: HIV Infection
Interventions: Procedure: GI endoscopy and GALT biopsies;   Biological: A sample of venous blood will also be collected
7 Completed Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC);   Drug: Tenofovir disoproxil fumarate (TDF);   Drug: Efavirenz (EFV);   Drug: Truvada
8 Active, not recruiting The Impact of Omega Three Fatty Acids on Vascular Function in HIV
Conditions: High Triglyceride Level;   HIV Infection
Intervention: Drug: Lovaza
9 Completed Isentress Re-examination Study (MK-0518-115)
Conditions: HIV Infection;   HIV Infections
Intervention:
10 Unknown  Notification of Donors With Positive Microbiology Markers
Conditions: Human Immunodeficiency Virus;   Hepatitis B;   Hepatitis C;   Human T-lymphotropic Virus I & II;   Creutzfeldt-Jakob Syndrome;   HIV Infections
Intervention:
11 Completed Preventative Misconception Intervention
Conditions: HIV;   HIV Infections
Interventions: Behavioral: 1-sided messages;   Behavioral: 2-sided messages
12 Completed Accelerated Aging, HIV Infection, Antiretroviral Therapies
Conditions: HIV Infection;   Aging Accelerated;   Antiretroviral Therapies
Intervention: Biological: Peripheral blood biological tests
13 Completed Cell Phone Reminders Intervention
Conditions: HAART Non-Adherence;   HIV;   HIV Infections
Intervention: Behavioral: Cell Phone Intervention
14 Unknown  A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir
15 Completed Treatment for Depression Among HIV-Infected Youth
Conditions: HIV;   Depression;   HIV Infections
Interventions: Behavioral: COMB - Combination Cognitive Behavioral Therapy and Medication Management;   Behavioral: TAU - Treatment as Usual
16 Completed A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: PF-04776548
17 Unknown  High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
Conditions: HIV-related Lymphoma;   HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT
18 Terminated Pre-Exposure Prophylaxis Using TMC278LA
Condition: HIV Infections
Intervention: Drug: TMC278LA
19 Completed Pre-Exposure Prophylaxis in YMSM
Condition: HIV
Interventions: Drug: coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP;   Drug: Placebo;   Behavioral: Many Men, Many Voices (3MV)
20 Terminated Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens
Condition: HIV Infections
Interventions: Drug: Maraviroc;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years